UCB1381
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCB1381, covering 2025-10-20 to 2025-10-20. Get the full timeline:
Most recent: Clinical Trial Update: A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B) [Phase 1, Phase 2]